One of the greatest challenges in tissue engineering has always been "vascularization"—getting blood to flow through a thick biological substitute to keep the cells alive. In early 2026, the industry has achieved a breakthrough with "pre-vascularized" scaffolds. These substitutes include "micro-fluidic" channels that are "pre-seeded" with endothelial cells (the cells that line blood...